Advances in computer science, genomics and molecular biology are redefining what we mean by personalised medicine. More and more, medical science is able to take advantage of differences between patients to generate individual treatments with improved efficacy and reduced risk of side effects. Dr Emma Davenport of the Wellcome Sanger Institute joins us to discuss the potential and limitations of personalised medicine today and her research which guides more personalised approaches to the treatment of sepsis.